11/15/2024
3:31 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
6:50 PM | Arcutis Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/13/2024
5:45 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:30 PM | Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/12/2024
10:34 AM | Arcutis Biotherapeutics (Subject)
Curran Terrie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:07 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
3:41 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/01/2024
1:51 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
2:24 PM | Arcutis Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
10/03/2024
3:55 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:55 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
2:32 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
8:42 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
2:51 PM | Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
4:56 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
12:37 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:39 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:43 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:45 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:10 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
07/02/2024
6:13 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:08 PM | Arcutis Biotherapeutics (Subject)
Smither John W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:47 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:03 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:50 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
2:39 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
6:38 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
4:12 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
2:58 PM | Arcutis Biotherapeutics (Subject)
Edwards Larry Todd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:06 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
2:27 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
2:28 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code…
And since then…
"In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide |
05/02/2024
2:29 PM | Arcutis Biotherapeutics (Subject)
Moore Matthew Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
2:31 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
7:30 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
7:32 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:12 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:14 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:08 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:09 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
11:40 AM | Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024
9:31 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A | |
03/04/2024
4:44 PM | Arcutis Biotherapeutics (Subject)
OSBORNE DAVID W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:47 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:38 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:40 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:42 PM | Arcutis Biotherapeutics (Subject)
Moore Matthew Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:21 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
02/27/2024
3:34 PM | Arcutis Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:48 AM | Arcutis Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:44 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
5:36 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:47 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:23 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I/A | |
02/15/2024
3:20 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
11:29 AM | Arcutis Biotherapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
8:26 AM | Arcutis Biotherapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
02/12/2024
8:52 AM | Arcutis Biotherapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/12/2024
5:06 AM | Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024
11:15 PM | Arcutis Biotherapeutics (Filer)
| Form EFFECT | |
02/08/2024
11:52 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G | |
01/31/2024
4:22 PM | Arcutis Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/29/2024
2:26 PM | Arcutis Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/23/2024
9:26 AM | Arcutis Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024
3:28 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:34 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:35 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:03 AM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I | |
01/03/2024
4:30 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
1:29 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:24 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
2:26 PM | Arcutis Biotherapeutics (Subject)
Turney Patricia A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
5:33 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
7:51 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
2:51 PM | Arcutis Biotherapeutics (Subject)
Burrows Scott L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
4:47 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
11/21/2023
2:36 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
